KARACHI, Dec 15 (NNN-APP) – The first ever traditional Chinese medicine (TCM) for bronchitis, the Yinhuang Qingfei Capsule, passed a one-year trial against its competitor antibiotic medicine, at a clinical research centre in Pakistan and has been declared suitable and effective for Pakistani population.
Raza Shah, general manager of the Bio-equivalence Studies and Clinical Research at the International Centre for Chemical and Biological Sciences (ICCBS), of the University of Karachi, presented the test conclusion report at a ceremony, and said that they conducted a randomised double-blind clinical trial of the efficacy and safety of the Yinhuang Qingfei Capsule of Anbang Pharmaceutical against Amoxicillin-Clavulanate, in patients with chronic simple bronchitis.
Amoxicillin, a widely used medicine in Pakistan, “is losing its potency against bacteria, due to resistance, so there was a need for alternate and Yinhuang Qingfei proved to be a good alternative,” said Shah, adding, the Chinese capsule was effective in Chinese population against bronchitis and the clinic trail in his research centre found it equally effective in Pakistani population with a curative index comparable to Amoxicillin.
A total of 212 patients were treated in the trial period and the effectiveness against cough rate in case of Yinhuang Qingfei was 72.8 percent and that of antibiotic Amoxicillin-Clavulanate was 71.8 percent, the report said.
On the occasion, Director of the ICCBS, Muhammad Iqbal Choudhary said, the trial of a traditional Chinese medicine for the first time in Pakistan, is a historic step which will open new opportunities of cooperation in the field of medicine between the two countries.– NNN-APP
